Osimertinib With Chemotherapy Could Aid Overall Survival for NSCLC

Benefits throughout post-progression endpoints and outcomes were reported for osimertinib in combination with chemotherapy.

Related Keywords

Susan Galbraith ,Astrazeneca ,Osimertinib With ,Line Treatment ,Completion Date ,